ANTI-PAR2 ANTIBODIES AND USES THEREOF

The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and ant...

Full description

Saved in:
Bibliographic Details
Main Authors DOBSON, Claire, WILLIAMS, Richard, GURRELL, Ian, FAIRMAN, David, PODICHETTY, Sadhana, THORNTON, Peter, NEWTON, Philip
Format Patent
LanguageEnglish
Published 03.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
AbstractList The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
Author NEWTON, Philip
WILLIAMS, Richard
FAIRMAN, David
GURRELL, Ian
THORNTON, Peter
PODICHETTY, Sadhana
DOBSON, Claire
Author_xml – fullname: DOBSON, Claire
– fullname: WILLIAMS, Richard
– fullname: GURRELL, Ian
– fullname: FAIRMAN, David
– fullname: PODICHETTY, Sadhana
– fullname: THORNTON, Peter
– fullname: NEWTON, Philip
BookMark eNrjYmDJy89L5WRQdfQL8dQNcAwyUgCxnPxdPF2DgUwXhdBgICPEwzXI1d-Nh4E1LTGnOJUXSnMzKLu5hjh76KYW5MenFhckJqfmpZbEhwYbGRgZG5kYmRlbOhoaE6cKAPhxJbA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023242639A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023242639A13
IEDL.DBID EVB
IngestDate Fri Jul 19 10:41:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023242639A13
Notes Application Number: US202318165614
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230803&DB=EPODOC&CC=US&NR=2023242639A1
ParticipantIDs epo_espacenet_US2023242639A1
PublicationCentury 2000
PublicationDate 20230803
PublicationDateYYYYMMDD 2023-08-03
PublicationDate_xml – month: 08
  year: 2023
  text: 20230803
  day: 03
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies MEDIMMUNE LIMITED
RelatedCompanies_xml – name: MEDIMMUNE LIMITED
Score 3.491536
Snippet The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANTI-PAR2 ANTIBODIES AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230803&DB=EPODOC&locale=&CC=US&NR=2023242639A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-LHlILaW7Bb2rQ9FOknVVhbulZ2G-2aw0DmcBX_fV9Cpzvt9pLAywd5X0neLwCPdIRWXhtZpGaUEZ1xk1RNJf7QqDjuD5MZhkgUniQsLvW3mTHrwcc2F0bihP5IcESUqAXKeyv19fr_ECuQbys3z_USqz5fosIJ1C46Rn_a0qgaeE6YpUHqq77vlFM1yWWbBCe3XYyVDoQjLZD2w3dP5KWsd41KdAqHGfJbtWfQ46sBHPvbv9cGcDTprryR7KRvcw5PblK8kszNx4qgvFT4ckgGSolaUSniMA_T6AIeorDwY4L9zf-mNy-nu4Ojl9DHwJ9fgVKbAr18XKEHwHW9MW00pZTaWmUvtMZi1jUM93G62d98CyeiKB-z0SH0269vfocGtq3v5br8Ajq8d_s
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDNLZh28zwEyZNUmwdpIr2VpNmDILXYiH_f2SXVnnobdmD2wc7OzO7MtwAPZIRWXh4ZUqURTVI0qktlXbI_NEqK-0PXVJUVCkexFhbKy1ydd-BjWwvDcUJ_ODgiatQS9b3h5_X6_xLL47mVm6fqHZs-n4Pc8sQ2OkZ_2pCJ6DmWnyZe4oquaxUzMc44j4OTmzbGSgc6w-dlztObw-pS1rtGJTiBwxTlrZpT6NBVH3ru9u-1PhxF7ZM3kq32bc7g0Y7ziZTa2VhglJMwXw5JTyjwVBTy0M_8JDiH-8DP3VDC_hZ_01sUs93BkQvoYuBPL0GodIZePi7RA6CKUusmmlJCTLk0l3JtaMYAhvskXe1n30EvzKPpYjqJX6_hmLF4YhsZQrf5-qY3aGyb6pav0S__EHro
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-PAR2+ANTIBODIES+AND+USES+THEREOF&rft.inventor=DOBSON%2C+Claire&rft.inventor=WILLIAMS%2C+Richard&rft.inventor=GURRELL%2C+Ian&rft.inventor=FAIRMAN%2C+David&rft.inventor=PODICHETTY%2C+Sadhana&rft.inventor=THORNTON%2C+Peter&rft.inventor=NEWTON%2C+Philip&rft.date=2023-08-03&rft.externalDBID=A1&rft.externalDocID=US2023242639A1